The Directorate General of Drug Administration (DGDA) has decided not to increase the price of stents, which was last adjusted in December, ignoring demands from importers.
“It has been decided to sell stents at the price fixed on 12 December 2023,” DGDA Deputy Director Nurul Alam said today (27 February) following a meeting at the health ministry.
Following the authorities’ decision in December, importers of stents from European countries recently sent a letter to the DGDA seeking a readjustment of stent prices.
The DGDA’s decision comes only hours after Health Minister Samanta Lal told reporters at the ministry that he directed authorities to take steps to reduce drugs and stents prices.